Boston Scientific Corporation
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| 0HOY.L | MMSI | MDT | OBIO | 7575.T | FOCL | |
|---|---|---|---|---|---|---|
| Market cap | — | 5.57B | 122.04B | 335.99M | 110.98B | 196.89M |
| P/E (TTM) | 86.0 | 38.4 | 23.4 | — | 11.9 | — |
| Forward P/E | — | 20.2 | 14.9 | -3.7 | 13.0 | -6.3 |
| Price/book | 2.6 | 3.3 | 2.4 | 17.4 | 1.7 | -48.5 |
| Dividend yield | — | — | 2.98% | — | 3.59% | — |
| 1-year change | +38.01% | +13.54% | +3.12% | +38.13% | +1.50% | +74.37% |
| Today | +2.27% | −0.68% | −1.22% | +2.19% | +1.35% | +0.48% |
The closest companies by business. Prices may be delayed up to 20 min.
Latest news
All 0HOY.L news ›Can Boston Scientific Stock Bounce Off This Support Again?
For questions about this article or underlying research, email [email protected]. Boston Scientific (BSX) shareholders have lost more than half their money over the past year. The stock posted a total return of -54.1%, compared with 17.1%…
NCC recalls certain Boston Scientific microcatheters over potential safety risks
Updated Oct. 20, 2026, 9:13 a.m. | By Kubobonke Luthuli The company has identified a manufacturing defect, which it says could pose a serious risk to patients The recall affects 199 units of the company’s tiny medical tubes, Direxion and…
Why Boston Scientific (BSX) Stock Is Down Today
Boston Scientific Corporation (BSX) is down 3.4% today. Here is some analysis on what might have caused this price movement. Analysis: The most likely driver is continued caution around the company’s August 2026 cybersecurity incident and…
Boston Scientific Stock Eyes Oct. 28 Outlook Reset [2026]
Boston Scientific is heading into one of the more closely watched earnings calls of the quarter. The cardiac and medical device maker confirmed it will report third-quarter 2026 results on October 28, 2026, before an 8:00 a.m. ET…
Boston Scientific: A Better Valuation, But The Turnaround Needs Proof
(NYSE:BSX) Seeking Alpha - Boston Scientific remains fundamentally strong, with a differentiated portfolio and favorable long-term industry trends anchoring its growth prospects. - BSX's recent financials showed solid revenue and margin…
Banque Pictet & Cie SA Sells 694,882 Shares of Boston Scientific Corporation $BSX
Banque Pictet & Cie SA trimmed its stake in shares of Boston Scientific Corporation (NYSE:BSX – Free Report) by 65.0% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The…
Lobbying Update: $642,000 of BOSTON SCIENTIFIC CORPORATION lobbying was just disclosed
$642,000 of BOSTON SCIENTIFIC CORPORATION lobbying was just disclosed, from Q3 of 2026, in a new Lobbying Disclosure Act filing. Members of Congress have traded $BSX stock 13 times in the past 6 months. Of those trades, 5 have been…
Baird Adjusts Price Target on Boston Scientific to $50 From $53
marketscreener.com Advanced Medical Equipment & Technology Baird Adjusts Price Target on Boston Scientific to $50 From $53 Published on 10/15/2026 at 07:47 am EDT
Perpetual Ltd Purchases 24,355 Shares of Boston Scientific Corporation $BSX
Perpetual Ltd increased its position in Boston Scientific Corporation (NYSE:BSX – Free Report) by 182.5% during the third quarter, according to its most recent Form 13F filing with the SEC. The fund owned 37,699 shares of the medical…
Leerink Partners Sticks to Their Buy Rating for Boston Scientific (BSX)
Leerink Partners analyst Mike Kratky maintained a Buy rating on Boston Scientific today and set a price target of $55.00. Kratky covers the Healthcare sector, focusing on stocks such as Boston Scientific, Edwards Lifesciences, and Insulet.…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
-
marketscreener.com17
-
theglobeandmail.com7
-
defenseworld.net6
-
themarketsdaily.com6
-
buffalonews.com3
Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 65 articles, not a forecast.